Who owns ADAGIO THERAPEUTICS INC?
- Ticker: IVVD
- CUSIP Number: 00534a102
Tip: Access positions for across all investors
Analyze quarterly positions in Adagio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adagio Therapeutics stock
Who bought or sold ADAGIO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Maverick Capital | 12M | $52M | 26% | Mar 2024 |
|
| M28 Capital Management | 9.2M | $36M | 0% | Dec 2023 |
|
| FMR | 8.4M | $37M | 4% | Mar 2024 |
|
| Alphabet | 4.5M | $20M | -20% | Mar 2024 |
|
| 683 Capital Management | 3.5M | $15M | -3% | Mar 2024 |
|
| OrbiMed Advisors | 2.7M | $12M | -35% | Mar 2024 |
|
| Vanguard Group | 2.6M | $12M | 4% | Mar 2024 |
|
| Bain Capital Life Sciences Investors | 1.8M | $8.0M | -7% | Mar 2024 |
|
| Millennium Management | 1.5M | $6.8M | 234% | Mar 2024 |
|
| Redmile Group | 1.4M | $6.4M | 0% | Mar 2024 |
|
| BlackRock | 877k | $3.9M | -23% | Mar 2024 |
|
| Marshall Wace | 755k | $3.4M | 2467% | Mar 2024 |
|
| TOMS Capital Investment Management | 750k | $3.3M | 100% | Mar 2024 |
|
| Susquehanna International | 624k | $2.8M | 942% | Mar 2024 |
|
| Geode Capital Management | 612k | $2.7M | 12% | Mar 2024 |
|
| Goldman Sachs Group | 603k | $2.7M | 1014% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 585k | $2.6M | 100% | Mar 2024 |
|
| Jacobs Levy Equity Management | 435k | $1.9M | 22% | Mar 2024 |
|
| Jane Street | 326k | $1.4M | 68% | Mar 2024 |
|
| Bridgeway Capital Management | 325k | $1.4M | -27% | Mar 2024 |
|
| Qube Research & Technologies | 312k | $1.4M | 1655% | Mar 2024 |
|
| Charles Schwab Investment Management | 311k | $1.4M | 2% | Mar 2024 |
|
| Squarepoint Ops | 285k | $1.3M | 178% | Mar 2024 |
|
| Acadian Asset Management | 204k | $905k | 100% | Mar 2024 |
|
| Barclays | 203k | $901k | 181% | Mar 2024 |
|
| Citigroup | 202k | $896k | -25% | Mar 2024 |
|
| Hrt Financial | 147k | $650k | 100% | Mar 2024 |
|
| Man Group | 142k | $631k | 100% | Mar 2024 |
|
| Rbf Capital | 140k | $622k | -31% | Mar 2024 |
|
| Two Sigma Investments | 136k | $603k | 139% | Mar 2024 |
|
| Marathon Trading Investment Management | 112k | $497k | 100% | Mar 2024 |
|
| Northern Trust | 111k | $492k | 4% | Mar 2024 |
|
| American Century Companies | 81k | $360k | 100% | Mar 2024 |
|
| Cubist Systematic Strategies | 81k | $359k | 215% | Mar 2024 |
|
| Balyasny Asset Management | 80k | $356k | -8% | Mar 2024 |
|
| a16z Perennial Management | 80k | $355k | 0% | Mar 2024 |
|
| Acuitas Investments | 77k | $343k | -63% | Mar 2024 |
|
| Point72 Asia | 75k | $333k | 4103% | Mar 2024 |
|
| Dimensional Fund Advisors | 66k | $291k | 100% | Mar 2024 |
|
| ExodusPoint Capital Management | 64k | $282k | 100% | Mar 2024 |
|
| Chase Investment Counsel Corp. | 61k | $271k | 100% | Mar 2024 |
|
| Chicago Partners Investment | 60k | $137k | 100% | Mar 2024 |
|
| Morgan Stanley | 60k | $264k | 69% | Mar 2024 |
|
| Dimension Capital Management Partners | 55k | $246k | 100% | Mar 2024 |
|
| Brevan Howard Capital Management | 50k | $222k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 44k | $195k | 234% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 42k | $187k | 100% | Mar 2024 |
|
| Y-Intercept | 32k | $142k | 100% | Mar 2024 |
|
| Bank Of Montreal | 29k | $120k | 100% | Mar 2024 |
|
| Toroso Investments | 28k | $126k | 100% | Mar 2024 |
|
| Citadel Advisors | 25k | $112k | -46% | Mar 2024 |
|
| Belvedere Trading | 24k | $108k | 100% | Mar 2024 |
|
| Leucadia National Corporation | 23k | $101k | -57% | Mar 2024 |
|
| XTX Topco | 23k | $100k | 19% | Mar 2024 |
|
| LMR Partners | 21k | $93k | 100% | Mar 2024 |
|
| Bank of America Corporation | 18k | $81k | -59% | Mar 2024 |
|
| JustInvest | 18k | $78k | 0% | Mar 2024 |
|
| Graham Capital Management | 17k | $77k | 100% | Mar 2024 |
|
| CTC Alternative Strategies | 17k | $73k | 100% | Mar 2024 |
|
| Tower Research Capital | 16k | $73k | 12% | Mar 2024 |
|
| Laurion Capital Management | 16k | $71k | 0% | Mar 2024 |
|
| Marquette Asset Management | 14k | $63k | -67% | Mar 2024 |
|
| SG Americas Securities | 13k | $56k | 100% | Mar 2024 |
|
| Polymer Capital Management | 11k | $49k | 100% | Mar 2024 |
|
| Mariner Wealth Advisors | 10k | $45k | -3% | Mar 2024 |
|
| Two Sigma Securities | 10k | $45k | 100% | Mar 2024 |
|
| Naples Global Advisors | 10k | $44k | 0% | Mar 2024 |
|
| Rathbones Brothers | 10k | $44k | 0% | Mar 2024 |
|
| Simplex Trading | 7.7k | $34k | 100% | Mar 2024 |
|
| Loring Wolcott Coolidge Fa | 2.0k | $4.4k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 1.9k | $8.2k | -74% | Mar 2024 |
|
| Royal Bank of Canada | 1.6k | $7.0k | 135% | Mar 2024 |
|
| UBS Group | 1.4k | $6.1k | -91% | Mar 2024 |
|
| Advisor Group Holdings | 1.3k | $5.6k | -80% | Mar 2024 |
|
| Trust Co Of Vermont | 1.3k | $5.6k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 680.00 | $3.0k | 1% | Mar 2024 |
|
| Point72 Asset Management | 600.00 | $2.7k | 100% | Mar 2024 |
|
| Aspire Private Capital | 200.00 | $888.000000 | 0% | Mar 2024 |
|
| NISA Investment Advisors | 6.00 | $27.000000 | 0% | Mar 2024 |
|
| Farther Finance Advisors | 1.00 | $4.000000 | 0% | Mar 2024 |
|
Who sold out of Adagio Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Verition Fund Management | Sep 2023 | 137k | $233k |
| Triatomic Management | Sep 2023 | 26k | $44k |
| Bank of New York Mellon | Dec 2023 | 26k | $101k |
| Group One Trading | Sep 2023 | 1.6k | $2.7k |
| Goss Wealth Management | Sep 2023 | 1.0k | $1.7k |
| Glassman Wealth Services | Dec 2023 | 200.00 | $788.000000 |